Form 8-K - Current report:
SEC Accession No. 0001104659-06-039769
Filing Date
2006-06-05
Accepted
2006-06-05 17:03:10
Documents
3
Period of Report
2006-05-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES a06-13007_18k.htm 8-K 41145
2 EX-10 a06-13007_1ex10d1.htm EX-10.1 21257
3 EX-10 a06-13007_1ex10d3.htm EX-10.3 161481
  Complete submission text file 0001104659-06-039769.txt   225458
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 0907
Type: 8-K | Act: 34 | File No.: 001-12493 | Film No.: 06886905
SIC: 2836 Biological Products, (No Diagnostic Substances)